Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 26, 2009, inter alia, to consider Unaudited Financial Results (Provisional) for the third quarter ending September 30, 2009 (Q3).
Test your strategy and compete with over 150,000 traders online!